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In the recent years minimally invasive mitral valve surgery (MIMVS) has become a well-established and increasingly used option
for managing patients with a mitral valve pathology. Nonetheless, whether the purported benefits of MIMVS translate into
clinically important outcomes remains controversial. Therefore, in this paper we provide an overview of MIMVS and discuss
results, morbidity, mortality, and quality of life following mitral minimally invasive procedures. MIMVS has been proven to be
a feasible alternative to the conventional full sternotomy approach with low perioperative morbidity and short-term mortality.
Reported benefits of MIMVS include also decreased postoperative pain, improved postoperative respiratory function, reduced
surgical trauma, and greater patient satisfaction. Finally, compared to standard surgery, MIMVS demonstrated comparable efficacy
across a range of long-term efficacy measures such as freedom from reoperation and long-term survival.
1. Introduction
Minimally invasive mitral valve surgery (MIMVS) has been
proven as a feasible alternative to conventional full sterno-
tomy approach with low perioperative morbidity and short-
term mortality [1, 2]. As a result, MIMVS is being employed
increasingly as routine approach in many centers worldwide
with excellent short-term and long-term results [3, 4].
During the past years, several studies on outcomes of
MIMVS have been published in the literature [5–7]. Further-
more, since the first description of MIMVS by Cohn et al.
[8] and Navia and Cosgrove [9] in the mid 1990s, various
minimally invasive approaches have been reported includ-
ing the parasternal, hemisternotomy, minithoracotomy, and
totally endoscopic approaches [10–12]. However, despite the
differences in surgical approaches, the shared goal of all
these MIMVS procedures is to avoid median sternotomy-
related complications such as infection, mediastinitis, and
nerve injuries [8, 13–19] and, at the same time, to provide
a safe and effective option for mitral valve surgery with the
clinical benefits associated with a minimal access approach.
Nonetheless, whether the supposed benefits of MIMVS
translate into clinical favorable outcomes still remains con-
troversial, and there are conflicting opinions about whether
minimally invasive surgery is ready for routine uptake in
place of conventional open mitral valve surgery.
In this paper we provide an overview of MIMVS and dis-
cuss results, morbidity, mortality, and quality of life following
mitral minimally invasive procedures.
2. Review Criteria
Papers selected for this review were identified on PUBMED
using the search terms “minimally invasive mitral valve
surgery.”
All articles were reviewed and references were selected on
the basis of historical contribution, number of patients, and
new contributions to the field.
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3. Surgical Procedure
MIMVS refers to a constellation of surgical techniques/tech-
nologies (Figure 1) that minimize surgical trauma through
smaller incisions compared with a conventional sternotomy.
Themost commonminimally invasive approach to themitral
valve includes a right minithoracotomy [8], a robotically
assisted right thoracic approach [20], and a partial ster-
notomy [21].
In 1923 Elliot Carr Cutler, in conjunction with his cardio-
logy colleague, Samuel Levine, performed a closed transven-
tricularmitral commissurotomy on a 12-year-old patient with
rheumaticmitral stenosis at the Peter Bent BrighamHospital.
The patient survived surgery but died of pneumonia 4
years postoperatively. In the following years, Cutler per-
formed seven more operations using his new cardiovalvulo-
tome. Unfortunately, this concept did not promote long-term
success and a moratorium for these operations was called
in 1929. However, this pioneering effort in 1923 was the
first successful operation to treat valvular heart disease by a
surgical technique [22].
A transseptal approach to the mitral valve was described
by Dubost and colleagues [23] using a biatrial incision and
transecting the septum whereas Guiraudon and associates
[24] described an approach via the right atrium.
By the mid 1990s, the success of laparoscopic operations
in general surgery renewed an interest in minimally invasive
approaches for cardiac surgery. During April and May 1996,
minimally invasive mitral valve operations were performed
on 25 patients by Navia and Cosgrove [8, 9]. All patients
underwent mitral valve repair performed through a small
right parasternal incision. Although the surgical field is
smaller than a median sternotomy, the mitral valve is posi-
tioned in the center of the incision, and, if the atrium is small,
extension of the incision over the dome of the left atrium
provides a substantial improvement of exposure. There were
no hospital deaths, reoperations for bleeding, embolic com-
plications, wound infections, or valve repair failures. No sinus
node dysfunction or atrioventricular dissociation resulted
[9].
From 1996 to 1997, Cohn et al. [8] presented 84minimally
invasive cases (41 aortic, 43 mitral) using a right parasternal
incision and excising the third and fourth costal cartilage.
For mitral valve replacement or repair, all incisions were
performed through a right parasternal incision, excising
the third and fourth costal cartilage. The right atrium was
exposed and opened after caval tapeswere put down, isolating
the right atrium. The aortic cross-clamp was applied before
incising the right atrium. A transseptal incision then was
made into the left atrium. Once the atrial septum was
incised, the mitral valve was repaired or replaced by standard
techniques [25, 26].
The operative mortality for mitral valve surgery was 0
(0%) of 43.There had been no perivalvular leaks in any of the
valves implanted, and there has been excellent visualization of
themitral valves as to perform complicated repairs, including
leaflet resection, chondroplasty, and commissuroplasty docu-
mented by intraoperative and postoperative transesophageal
echo [8]. Smaller incisions lateral to the sternum have
been introduced, with or without resection of the third or
fourth costal cartilage.However, their disadvantages included
femoral CPB cannulation, ligation of the right internal thora-
cic artery, occasional chest wall instability, and difficult
conversion to full sternotomy [4].
In 1996, Carpentier et al. [27] performed the first video-
assistedmitral valve repair through aminithoracotomy using
ventricular fibrillation.
From 1996 to 1998 the Leipzig group [28] studied one
hundred and twenty-nine patients with nonischemic mitral
valve disease undergoing 3D video assisted mitral valve
surgery via a 4 cm right lateral minithoracotomy using
femorofemoral bypass and endoaortic clamping. After the
initial series (group I, 𝑛 = 62), a voice controlled robotic
arm (AESOP 3000, Automated Endoscope System for Opti-
mal Positioning; Computer Motion, Santa Barbara, CA)
was employed to guide the video scope in the last series
(group II, 𝑛 = 67). Finally, intraoperative transesophageal
echocardiography was introduced for real-time monitoring
of cardiac distention, deairing, and cannula placement [29].
Felger et al. [30] evaluated a series of video-assisted min-
imally invasive mitral operations, showing safe progression
toward totally endoscopic techniques. Consecutive patients
with isolated mitral valve disease underwent either manually
directed (𝑛 = 55) or voice-activated robotically directed
(𝑛 = 72) video-assisted mitral operations. The consecutive
series was evaluated in five cohorts comparing serial cross-
clamp and perfusion times. Cold blood cardioplegia, a
transthoracic aortic clamp, a 5mm endoscope, and a 5 cm
minithoracotomy were used. This video-assisted minimally
invasive mitral operation cohort was compared with a pre-
vious sternotomy-based mitral operation cohort (𝑛 = 100).
Repairs were performed in 61.8% manually directed (MD,
𝑛 = 34), 75.0% robotically directed (RD, 𝑛 = 54), and
54% sternotomy-based (𝑁 = 54) mitral operations. The
robotically directed technique showed a significant decrease
in blood loss, ventilator time, and hospitalization compared
with the sternotomy-based technique. Manually directed
mitral operations compared with robotically directed mitral
operations had decreased arrest times (128.0 ± 4.5 minutes
compared with 90.0 ± 4.6minutes; 𝑃 < 0.001) and decreased
perfusion times (173.0 ± 5.7minutes compared with 144.0 ±
4.6 minutes; 𝑃 < 0.001). In the minimally invasive mitral
operation cohort, complications included reexploration for
bleeding (2.4%; 𝑛 = 3) and one stroke (0.8%), whereas the
30-day mortality was 2.3% (𝑛 = 3). Operative times were
significantly less with RD operations versus MD operations
(𝑃 < 0.002) Table 1.
The next evolutionary bound in endoscopic mitral
surgery was the development of three-dimensional (3D)
vision and computer-assisted telemanipulation that could
transpose surgical movements from outside the chest wall
todeep within cardiac chambers; in that same year, Carpen-
tier et al. [47] performed the first completely robotic MVR
using the Da Vinci Surgical System (Intuitive Surgical,Inc.,
Sunnyvale, California, USA). Soon after, the East Carolina
University group performed the firstmitral valve replacement
through a minithoracotomy, using video direction [8, 20].
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Minimally invasive valve surgery
Thoracotomy
Right anterior thoracotomy, second and third intercostal spaces
Right anterior thoracotomy, fourth and fifth intercostal spaces
Left lateral thoracotomy
Left posterior thoracotomy
Right vertical infra-axillary thoracotomy
Partial sternotomy
Parasternal incision
Transternal incision
Upper sternotomy
T mini sternotomy
Inverted T sternotomy
Reversed L-shaped partial upper sternotomy
Reversed L incision
J incision
V incision
Video-assisted
Port access
Robot-assisted
AESOP 3000
da Vinci
Zeus
Figure 1: Minimally invasivemitral valve surgery: techniques overview.
Table 1: Most recent observational cohort studies of minimally invasive mitral valve surgery.
Authors Year
Minimally
invasive
(number of
patients)
Minithoracotomy
(number of
patients)
Approach Valve Differences
Cohn et al. [8] 1997 50 50 PS, UHS MV, AV Longer CBP/XT times in MI group
Navia and Cosgrove [9] 1996 31 100 MT MV
Longer CBP/XT times, less transfusion,
reduced CVA, shorter
ICU/hospital stays in MI group
Glower et al. [31] 1998 21 20 MT MV Longer CBP/XT times, shorter return tonormal activity time n MI group
Reichenspurner et al.
[32] 1998 100 100 MT MV Reduced AF in MI group
Asher et al. [33] 1999 100 100 — MV, AV Longer CBP/XT times, shorter hospital staysin MI group
Grossi et al. [34] 1999 111 259 MT MV, AV Lower sepsis/wound complications, shorterhospital stays in MI group
Walther et al. [35] 1999 129 209 MT MV, AV Lower pain levels
Schneider et al. [36] 2000 21 13 MV MT Longer CPB time
Hamano et al. [37] 2001 21 27 PS, UHS, LHS MV, AV No differences
Grossi et al. [38] 2001 100 100 MT MV No differences
Grossi et al. [39] 2001 109 88 MT MV, AV Longer CBP/XT times, shorter hospital staysin MI group
Felger et al. [30] 2001 127 100 MT MV
With AESOP shorter hospital stay time
compared to ST group, shorter XC times
compared to manually directed videoscope
Yamada et al. [40] 2003 66 50 LHS MV, AV Longer CBP/XT times in MI group
McCreath et al. [41] 2003 214 87 MT MV Reduced acute renal deseas in MI group
de Vaumas et al. [42] 2003 10 10 PS MV Longer CBP/XT times in PS group
Gaudiani et al. [43] 2004 205 616 UHS, LHS, MT MV Shorter hospital stay in MI repair group, lessCVA in MI replacement group
Mihaljevic et al. [44] 2004 474 337 LHS, PS MV 5-year survival better for MI group
Dogan et al. [45] 2005 20 20 MT MV Intraoperative complications in EABOgroup
Ryan et al. [46] 2005 117 117 MT MV Longer CBP/XT times in MI group
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Another promising technique is the Port access for
MIMVS [31, 48–50].
Stevens and colleagues at Stanford University introduced
in Europe in March 1996 a surgical method for performing
Port-access bypass grafting [51].
In 1998, Mohr reported the Leipzig University experi-
ence using the Port access technology, which was based on
endoaortic balloon occlusion (EABO).The study recruited 51
consecutive patients with nonischemic mitral valve disease
who undergone mitral repairment (𝑛 = 28) or replacement
(𝑛 = 23) by means of a minimally invasive approach through
a right lateral minithoracotomy and under videoscopic guid-
ance. Acute retrograde aortic dissection occurred in two
patients [50]. Both events were most likely caused by intimal
dissection at the level of the iliac artery induced by the
guide wire. Retrograde flow led to complete retrograde aortic
dissection.
The Port access technology has some complicated aspects
such as the introduction and the placement of the endoaortic
balloon catheter and its intraoperative monitoring. Trans-
esophageal echocardiography and fluoroscopy are used to
verify proper positioning of the coronary sinus and pul-
monary artery vent catheters and the venous drainage can-
nula and endoaortic balloon [52, 53]. During CPB, verifica-
tion of proper positioning of the endoaortic balloon is vital
because proximal migration can damage the aortic valve and
distal migration can decrease cerebral perfusion by occluding
the brachiocephalic artery [52]. Because distal migrationmay
compromise cerebral blood flow, it is imperative to monitor
endoaortic balloon position continuously. Multiple monitor-
ing techniques are used to confirm proper positioning of the
endoaortic balloon in the ascending aorta. Transesophageal
echocardiography is useful in visualizing the ascending aorta
and endoaortic balloon location [54], but it may become
difficult to visualize the balloon position when the heart is
fully arrested during CPB.
The implementation of continuous transcranial Doppler
flow measurements of the middle cerebral arteries added
an important safety measure, as right radial artery pressure
measurements alone are not sensitive enough to immediately
detect impairment of cerebral perfusion caused by balloon
migration to the aortic arch [11].
However, the Port access technique still continues to be
associated with significant risks such as peripheral CPB can-
nulation and a high rate of retrograde aortic dissection bal-
loon catheter to occlude the aorta and provide cardioplegia.
An 8 cm anterolateral thoracotomy via the third inter-
costals space, direct aortic clamping, and cannulation has
been described by Angouras and Michler [55].
Telemanipulators, robotics that allow a hand-like mecha-
nism to be controlled by a human operator, were first used by
Mohr et al. [28] and Falk et al. [11].
Chitwood et al. [56, 57] and Kypson et al. [58, 59]
showed that this technique could be safely and effec-
tively used. Recently, another group reported the results of
25 patients receiving successful telemanipulator-supported
MIMVS [60]; however, long-term results are not available.
Other centers had similar positive experiences using the
telemanipulator-supported techniques in the late 1990s [61,
62]. However, they later abandoned this technique, given the
lack of difference compared with their standard approaches.
In 2009, Wang et al. [63] presented a new approach for MV
replacement through a right vertical infra-axillary thoraco-
tomy with excellent results (0.5% mortality).
4. Mortality
After reviewing all comparative miniVS studies evaluating
mortality, no study showed a significant difference between
minimally invasive and conventional approaches [32, 34, 38,
39, 42, 43, 46, 64].
Mihaljevic et al. compared 474 minimally invasive mitral
operations (mostly lower sternotomy and right parasternal)
with 337 median sternotomy procedures. The perioperative
mortality was 0.2% for the minimally invasive group and
this is compared favorably with 0.3% in the sternotomy
patients. However, the MIMVS patients were found to be
a lower risk group (better ejection fraction, more repairs,
less symptomatic), and no attempt was made to adjust for
these differences [44]; Furthermore, Grossi et al. matched 100
consecutive patients undergoing minimally invasive aortic
and mitral valve surgery over a 2.5-year period (through
either a 3rd or 4th interspace incision) to patients having the
same valve surgery via a sternotomy [38].They demonstrated
no significant difference in hospital mortality (3.7% versus
3.4%, resp.) between groups, even though mean CPB times
was 30 min longer in the minimally invasive group. Six
studiesmet the inclusion criteria for our analysis and revealed
no significant mortality difference between groups (1,641
patients, OR 0.46, 95%CI 0.15–1.42,𝑃 = 0.18) [38, 43, 44, 46].
5. Neurological Events
Due to the physical limitations of MIMVS, inadequate de-
airing leading theoretically to a higher incidence of neuro-
logical complications was a primary concern, making the use
of transesophageal echocardiography mandatory. In his early
series, Mohr [50] reported an 18% incidence of postoperative
confusion; however, continuous Co
2
insufflation was not
used, as in more recent series. One decade later, Seeburger
et al. [3] observed postoperative neurological impairment in
41 of 1,339 patients (3.1%) who underwent mini MVS, with 28
(2.1%)minor and 13 (1.0%)major events. Ten studies reported
no difference in the incidence of stroke [31, 39, 65, 66], while
two showed a decreased incidence following a minimally
invasive approach [43, 67]. In a systemic metaanalysis [3],
there was no significant difference in neurological events in
6 eligible studies including a total of 1,801 patients.
Schneider et al. used transcranial Doppler to detect cereb-
ral microemboli in 21 MIMVS patients undergoing endoaor-
tic balloon occlusion with continuous Co
2
chest cavity insuf-
flation. These were compared to 14 patients undergoing
conventional mitral surgery [36]. They found no significant
difference in the cerebral microembolic rate between either
technique.
The Consensus Statement of the International Society of
Minimally Invasive Coronary Surgery (ISMICS) 2010, based
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on a systematic review and meta-analysis of all available ran-
domized and nonrandomized comparative trials of isolated
mini versus conventional mitral valve surgery (two random-
ized trials and 33 nonrandomized studies for a total of 35
studies) [68], associated some adverse clinical outcomes with
miniMVS comparedwith conv-MVS, including stroke, aortic
dissection, and groin wound/vasculature complications. The
absolute risk increase of stroke for mini MVS versus conv-
MVS was 0.9% overall (2.1% versus 1.2%, RR 1.79, 95% CI
1.35–2.38; 13 studies, level B). Subanalysis of two propensity
comparison studies also showed significant increase of stroke
of 1% with mini MVS compared with conv-MVS (1.9% versus
0.9%, RR 2.02, 95% CI 1.40–2.94; two studies, level B) [69].
These findings are similar to those recently reported by
a recent Society ofThoracic Surgeons-Adult Cardiac Surgical
Database (STS-ACSD) publication made on 28,143 patients
undergoing isolated mitral valve operations that examined
the associations between operative strategy and the increased
risk of stroke in the less-invasive group [70].
The markedly higher rate of permanent perioperative
stroke in the less-invasive group compared with the conven-
tional sternotomy group in unadjusted, adjusted, and propen-
sity analyseswas themost significant finding of this study.The
adjusted OR for permanent stroke was 1.96 for less-invasive
compared with conventional sternotomy operations in the
multivariable analysis, and the likelihood of stroke was simi-
larly increased in the propensity analysis. Among the 4,322
LIMV operations, there were 41 excess strokes compared
with the propensity-matched group having conventional
mitral valve operations. Additional analyses demonstrated a
threefold higher risk of stroke for less-invasive operations
performed without aortic occlusion (beating- or fibrillating-
heart), which comprised 12% of the less invasive group.
Femoral cannulation was not an independent predictor of
stroke [70].
Grossi et al. [71] using an informal strategy of intra-
operative echocardiographic analysis of the aortic arch and
the descending aorta in 714 minimally invasive mitral valve
procedures had excellent results from this approach avoiding
the use of femoral perfusion when there was significant
atherosclerotic burden [71]. In this cohort, where 30% of
patients were >70 years of age, 15% were reoperations, and
12% were multivalve operations, femoral perfusion was used
in nearly 80% of patients, with a 2.9% incidence of stroke.
Afterwards they developed an aortic cannulation through a
minithoracotomy incision that became the “go-to” approach
for the majority of our minimally invasive mitral valve
procedures, regardless of age.
The same group [72] reviewed a large minimally invasive
valve experience using a robust data collection instrument.
The study recruited 3,180 patients undergone to isolated, non-
reoperative valve operations: 1,452 (45.7%) aortic valve
replacements and 1,728 (54.3%) mitral valve procedures. The
surgical approach was with standard sternotomy (𝑛 = 889;
28%) or by minimally invasive techniques (𝑛 = 2, 291;
72%). Antegrade arterial perfusion was used in 2,646 (83.2%)
cases and retrograde perfusion was used in 534 (16.8%)
cases.Multivariable analysis revealed that age, atherosclerotic
aorta, cerebrovascular disease, emergent procedure, ejection
fraction less than 0.30, no use of aortic clamp, and retro-
grade perfusion were significantly associated with stroke. In
patients 50 years old or younger (𝑛 = 662), retrograde
perfusion hadno significant impact on the incidence of stroke
(1.6% versus 1.1%, 𝑃 = 0.57). In this study, minimally invasive
approaches for isolated aortic or mitral valve operations
did not increase the perioperative risk of stroke when per-
formed with antegrade perfusion. However, the risk of stroke
did increase with the use of retrograde perfusion in older
patients. Multivariable risk factors for stroke were retrograde
perfusion (odds ratio 4.4; 𝑃 < 0.01) and ejection fraction
below 0.30 (odds ratio 2.1; 𝑃 = 0.09). The authors concluded
that the incidence of stroke in reoperative mitral operations
was associated with perfusion strategies and not with the
surgical approach [71]. The overall stroke rate was 2.2%,
with increased stroke risk associated with an atherosclerotic
aorta, cerebrovascular disease, emergent operation, ejection
fraction <30% or retrograde perfusion (𝑃 < 0.05 for each),
but not with incision location (𝑃 = 0.82). Additionally,
the association of retrograde perfusion became insignificant
when analyzing patients who were 50 years old or younger
[72].
These results mirror those of a previous cohort of
patients undergoing reoperative mitral valve procedures,
which revealed that retrograde perfusion was the only inde-
pendent risk factor for stroke (odds ratio 4.4;𝑃 = 0.001) [73].
Later, Grossi and colleagues presented a focused report
on a more homogeneous subset of 1,282 first-time, isolated
mitral valve operations performed through a right anterior
minithoracotomy over a 12-year period [74]. This homo-
geneity allowed us greater discriminatory power to analyze
the specific patient factors associated with an increased risk
of stroke. The only significant risk factor interaction for
neurologic complication identified was the use of retrograde
perfusion in patientswith high-risk comorbidities: peripheral
vascular disease, cerebrovascular disease, atherosclerotic aor-
tas, or dialysis dependence.
These data suggest that retrograde perfusion remains a
viable option for younger patients without vascular comor-
bidities. In older patients or those with the risk factors
discussed previously, performing a computed tomography
angiography of the descending aorta with distal runoff in
addition to an intraoperative transoesophageal echocardio-
graphic assessment of the thoracic aorta [74, 75] is currently
recommend. Such an approach has been shown to be effective
by Murphy et al. [76], who demonstrated a 1.6% stroke rate
using retrograde perfusion in similarly screened patients
undergoing robotic cardiac procedures. Minimally invasive
valve surgery with antegrade perfusion has a low risk of
neurological complications and has excellent outcomes. Ret-
rograde perfusion in older patients with significant vascular
comorbidities is associated with an increased risk of stroke.
The vast majority of patients currently undergo heart valve
procedures through a right anterior minithoracotomy with
antegrade perfusion via direct ascending aorta cannulation
obviating the concerns associated with retrograde perfusion.
For those procedures in which the direct access to the
ascending aorta is extremely limited, in a recent editorials
Yaffee et al. [75] recommend preoperative aortic screening to
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identify aortic pathology and to avoid retrograde perfusion
in patients where high atheroembolic risk exists.
6. Bleeding, Transfusion, and Reexploration
A reduction in postoperative hemorrhage and transfusion
requirements has been suggested as a potential advantage of
minimally invasive valve surgery. This benefit is important
given the significant morbidity and mortality associated with
transfusions and reexploration for bleeding [77]. Smaller
incisions should theoretically reduce postoperative bleeding
and transfusion requirements, notably with the significant
morbidity/mortality associated with transfusions and bleed-
ing reexploration. Some studies report no difference in trans-
fusion requirements [45]. Four comparative studies reported
blood loss volume with three utilizing a minithoracotomy
[28, 31, 66] and one selecting a parasternal approach [42].
Mohr et al. demonstrated no difference in blood loss
or blood product transfusions in 31 videoscopic mitral pro-
cedures compared with a conventional sternotomy, despite
fewer reexplorations for bleeding [28]. The robotically
directed technique showed a significant decrease in blood loss
as well as ventilator time and hospitalization compared with
the sternotomy-based technique [30]. Felger et al. reported
that there was no significant difference either in percentage
of patients receiving transfusions or in the amount of packed
red blood cells, fresh frozen plasma, or platelets transfused;
however, postoperative chest tube drainage was significantly
less inminimally invasive patients comparedwith sternotomy
patients (𝑃 = 0.006). Because extreme values skewed the raw
data for ventilator hours, a rank order analysis of variancewas
performed to provide homogeneity of the data. The ranked
ventilator hours revealed a significant difference between
conventional and minimally invasive patients (𝑃 = 0.006),
but no difference was found between the RD and MD
patients (𝑃 = 0.984). All three cohorts had similar intensive
care unit lengths of stay (𝑃 = not significant). However,
length of stay from operative procedure to discharge was
significantly less in the RD and MD cohorts compared
with conventional cohorts (𝑃 = 0.001). In all minimally
invasive mitral valve operations the bleeding was controlled
through the thoracotomy incision without the need for
extension. However, there was no significant difference either
in the percentage of patients receiving transfusions or the
amount of blood products transfused [30] In addition, in
a prospective, randomized trial, Dogan et al. [45] found a
significant decrease in postoperative chest tube output in the
miniVS group compared with the conventional group. In a
consecutive series of 41 patients undergoing either Port access
(𝑛 = 21) or sternotomy (𝑛 = 20) mitral surgery, Glower
et al. demonstrated no significant difference in chest tube
drainage or transfusion requirements despite longer CPB
times in the former [31]. Grossi et al. [39] found that a right
thoracotomy was associated with 51% fewer blood products
than a conventional sternotomy.
In robotically assisted MVR, transfusion requirements
are even lower (20% to 45% require transfusions) [11, 78].
Furthermore, 4 comparative studies found less blood loss: a
minithoracotomy was used in 3 [26, 30, 31] and a parasternal
approachwas used in 1 [42].Three of 10 studies found reduced
transfusion requirements with aminimally invasive approach
compared with conventional surgery [8, 34, 38] whereas the
others showed no difference [31, 33, 42, 46, 65, 67, 77].
More convincing evidence came from a subsequent study
by the same group that showed 13% fewer total transfusions
with 1.8 fewer units of red blood cells using a minithoraco-
tomy compared to a sternotomy [39].
Similar data from Cohn et al. confirm that patients
undergoing minimally invasive valve surgery are transfused
1.8 units less compared to a conventional cohort [8]. Two
of seven studies [56, 65] demonstrated a reduced need for
reoperation for bleeding with a minimally invasive approach
[38, 42, 44, 46]. Further, 5 studies showed a significant
reduction in reoperations for bleeding with a minimally-
invasive approach [32, 38, 42–44, 49, 64]. The recent data
from the Leipzig group on postoperative course included
reoperation for bleeding in 69 patients (5.1%) [3].
7. Atrial Fibrillation
It has been suggested that a less traumatic surgical approach
would be a less potent trigger of postoperative AF. Nonethe-
less, 5 of 6 studies demonstrated that this is not the case [10,
30–33, 46], and onmeta-analysis of four eligible studies, there
was no significant difference betweenminimally invasive and
sternotomy approaches (539 patients, OR 0.86, 95% CI 0.59–
1.27, 𝑃 = 0.45).
Asher et al. [33] addressed this question in a cohort of
100 patients having elective primary minimally invasive AV
or MV surgery compared with a matched control group
undergoing conventional sternotomy. They found a similar
prevalence of post-operative AF using either method, even
after stratifying for valve type. However, the PAIR registry
reported a 10% incidence of new-onset AF with the port
access technique, which is lower than that expected for
sternotomy [33].
8. Septic Complications
The incidence of wound infections and septic complications
is lower with a thoracotomy than with a median sternotomy.
Of the three studies of minithoracotomymitral valve surgery
that reported wound complications compared to median
sternotomy, Grossi et al. reported an incidence of 0.9% and
5.7% forminithoracotomy and sternotomy cases, respectively
(𝑃 = 0.05) [34].This increased to 1.8% and 7.7%, respectively,
in elderly patients (𝑃 = 0.03) [34], whereas Felger et al.
reported no significant difference [30].
9. Pain, Quality of Life and Speed of Recovery
Compared with a complete sternotomy, thoracotomy inci-
sions are associated with less pain, discomfort, and post-
operative analgesics [30]. Cohn’s data show less pain in
hospital and after discharge, less analgesic usage, greater
patient satisfaction, and a return to normal activity 4.8 weeks
ahead of sternotomy patients [8].
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The most insightful evidence comes from 2 studies
reporting that patients undergoing surgery via a minimally
invasive approach as their second procedure all thought
that their recovery was faster/less painful than their original
sternotomy [30, 79].
10. Elderly Patients
Iribarne et al. demonstrated that MIMVS can be performed
safely in patients at ≥75 years old [80]. Although the mini-
mally invasive approach was associated with slightly longer
CPB and cross clamp times than was the conventional
sternotomy approach, there were no significant differences in
postoperative morbidity and mortality. Importantly, patients
undergoing MIMVS had approximate 3 days shorter mean
and 1 day shorter median durations of hospitalization, a
finding that has important implications for resource use.
There were significant reductions in both mean and median
costs of hospitalization associated with the minimally inva-
sive approach, a finding that correlates with the observed
difference in duration of hospitalization found between the
groups. In addition, patients undergoing MIMVS had faster
rates for both time to independent ambulation and time to
independent sit-to-stand activity [80]. Grossi et al. analyzed
111 patients undergoing MIMVS who were at least 70 years
old and compared these to 259 patients having a sternotomy
and concluded that this approach can be used safely in
operations on the elderly population with excellent result
[34]. Felger et al. recently reported 123 cases of minimal
invasive mitral valve repair in patients aged ≥70 years with
1.6% operative mortality as well as 5-year actuarial survival of
87% and 5-year freedom from reoperation of 93% [30, 79]. To
date, no studies have assessed any difference in postoperative
functional status by type of surgery.
11. Hospital Stay and Costs
Some of the reported benefits of MIMVS include decreased
intensive care unit a and total hospital length of stay,
faster physical rehabilitation, and decreased overall hospital
resource use [35, 40, 81, 82]. MIMVS is a cost-effective and
cost-saving strategy for mitral valve repair and replacement
compared with the traditional approach with lower cost
driven largely by a decreased length of stay [80].
12. Conclusions
MIMVS has been proven to be a feasible alternative to the
conventional full sternotomy approach with low periopera-
tive morbidity and short-term mortality.
Reported benefits of MIMVS include decreased postop-
erative pain, improved postoperative respiratory function,
reduced surgical trauma, and greater patient satisfaction.
Finally, compared to standard surgery,MIMVSdemonstrated
comparable efficacy across a range of long-term efficacy
measures such as freedom from reoperation and long-term
survival.
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